Spectral imaging and spectromicroscopy confirm SIGMOLECS® peptides permeate deep tissue of the skin to the hypodermis, and to the extracellular matrix of connective tissue and joints.
Sigmolecs® uses specific peptide combinations and ratios in a proprietary technology that allows penetration within the extracellular matrix and across cell membranes to reach target areas where they signal regenerative responses; such as cartilage regeneration within the joint.
The medical device that developed from this technology is a non-invasive transdermal formula that is used by orthopaedic physicians in the treatment of conditions such as osteoarthritis.